Camlin Fine Sciences Limited Total Liabilities
Camlin Fine Sciences Limited total liabilities. Based on the latest financial reports, Camlin Fine Sciences Limited (CAMLINFINE) has total liabilities worth Rs11.77 Billion INR (≈ $127.27 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check CAMLINFINE financial resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Camlin Fine Sciences Limited (2007–2025)
Total liabilities of Camlin Fine Sciences Limited from 2007 to 2025. This chart illustrates how Camlin Fine Sciences Limited's total liabilities have evolved over time, based on quarterly financial data. Explore CAMLINFINE strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Camlin Fine Sciences Limited Competitors by Total Liabilities
The table below lists competitors of Camlin Fine Sciences Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Genomictree Inc.
KQ:228760
|
Korea | ₩5.45 Billion |
|
HMA AGRO INDUSTRIES ORD (BSE)
NSE:HMAAGRO
|
India | Rs-9.62 Billion |
|
Phoenix Materials Co. Ltd
KQ:050090
|
Korea | ₩3.30 Billion |
|
Elanor Commercial Property Fund
AU:ECF
|
Australia | AU$213.27 Million |
|
Intermedia Capital Tbk
JK:MDIA
|
Indonesia | Rp3.35 Trillion |
|
Phuoc Hoa Rubber JSC
VN:PHR
|
Vietnam | ₫1.90 Trillion |
|
Goodbaby International Holdings Limited
F:GBH
|
Germany | €4.34 Billion |
|
Zig Sheng Industrial Co Ltd
TW:1455
|
Taiwan | NT$3.39 Billion |
Liability Composition Analysis (2007–2025)
This chart breaks down Camlin Fine Sciences Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Camlin Fine Sciences Limited balance sheet assets.
Liquidity & Leverage Metrics
Camlin Fine Sciences Limited Total Liabilities Ratios Explained
Camlin Fine Sciences Limited total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.36 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.14 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.32 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.58 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Camlin Fine Sciences Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Camlin Fine Sciences Limited (2007–2025)
The table below shows the annual total liabilities of Camlin Fine Sciences Limited from 2007 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | Rs11.49 Billion ≈ $124.26 Million |
+4.95% |
| 2024-03-31 | Rs10.95 Billion ≈ $118.40 Million |
-11.43% |
| 2023-03-31 | Rs12.36 Billion ≈ $133.67 Million |
+19.42% |
| 2022-03-31 | Rs10.35 Billion ≈ $111.93 Million |
+34.69% |
| 2021-03-31 | Rs7.68 Billion ≈ $83.11 Million |
-0.71% |
| 2020-03-31 | Rs7.74 Billion ≈ $83.70 Million |
+17.89% |
| 2019-03-31 | Rs6.57 Billion ≈ $71.00 Million |
+12.59% |
| 2018-03-31 | Rs5.83 Billion ≈ $63.06 Million |
+31.83% |
| 2017-03-31 | Rs4.42 Billion ≈ $47.84 Million |
+44.32% |
| 2016-03-31 | Rs3.06 Billion ≈ $33.15 Million |
+3.96% |
| 2015-03-31 | Rs2.95 Billion ≈ $31.88 Million |
+5.54% |
| 2014-03-31 | Rs2.79 Billion ≈ $30.21 Million |
-8.14% |
| 2013-03-31 | Rs3.04 Billion ≈ $32.89 Million |
+30.68% |
| 2012-03-31 | Rs2.33 Billion ≈ $25.17 Million |
+68.51% |
| 2011-03-31 | Rs1.38 Billion ≈ $14.93 Million |
+52.13% |
| 2010-03-31 | Rs907.72 Million ≈ $9.82 Million |
+41.38% |
| 2009-03-31 | Rs642.05 Million ≈ $6.94 Million |
+62.34% |
| 2008-03-31 | Rs395.50 Million ≈ $4.28 Million |
+4.62% |
| 2007-03-31 | Rs378.01 Million ≈ $4.09 Million |
-- |
About Camlin Fine Sciences Limited
Camlin Fine Sciences Limited, together with its subsidiaries, research, develops, manufactures, and markets specialty chemicals, ingredients, and additive blend products in India and internationally. The company offers shelf-life solutions, which include basic ingredients, such as tert-butylhydroquinone (TBHQ), Butylated Hydroxyanisole (BHA), Butylated Hydroxytoluene (BHT), and Ascorbyl Palmitate… Read more